Tezepelumab Is the First Biologic to Significantly Reduce Exacerbations in Broad Population of Patients With Severe, Uncontrolled Asthma

No Water, No Power and Freezing Temperatures for Some Texas Employees

When the cold storms hit Texas, some wondered how bad could it get. Three Amgen staffers share their experiences from Austin, San Antonio and Houston areas.

Sharpening the Focus on Supplier Diversity and Health Equity

Amgen commits to doubling supplier diversity spend by 2023 as it builds more external relationships with advocacy groups in the context of health equity.

The Transformation of Amgen’s Black Employee Network (ABEN): How to Impact the Business in Six Steps

Meet the Scientist Who Left Academia to Investigate a Medicine for Asthma Patients

Visit Our KRAS G12C Information Center

Learn more about our pioneering research in taking on one of cancer research’s toughest challenges, and hear first-hand from patients and Amgen scientists.